7459
MEDIPAL HOLDINGS CORPORATION
メディパルホールディングス
- Industry
- Wholesale Trade
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
3,211,125
Mar 2022
3,290,921
Mar 2023
3,360,008
Mar 2024
3,558,732
Mar 2025
3,671,328
Operating profit(million JPY)
Mar 2021
38,576
Mar 2022
45,624
Mar 2023
48,972
Mar 2024
47,330
Mar 2025
55,609
Operating profit margin(%)
Mar 2021
1.2
Mar 2022
1.39
Mar 2023
1.46
Mar 2024
1.33
Mar 2025
1.51
Profit before tax(million JPY)
Mar 2021
49,237
Mar 2022
57,284
Mar 2023
70,061
Mar 2024
74,741
Mar 2025
76,734
Profit(million JPY)
Mar 2021
23,926
Mar 2022
29,423
Mar 2023
38,806
Mar 2024
41,474
Mar 2025
40,279
Total assets(million JPY)
Mar 2021
1,679,934
Mar 2022
1,709,474
Mar 2023
1,703,871
Mar 2024
1,799,127
Mar 2025
1,824,984
Cash and cash equivalents(million JPY)
Mar 2021
240,047
Mar 2022
260,450
Mar 2023
193,561
Mar 2024
228,084
Mar 2025
259,337
Cash flows from operating activities(million JPY)
Mar 2021
34,448
Mar 2022
61,216
Mar 2023
16,146
Mar 2024
61,843
Mar 2025
60,559
Cash flows from investing activities(million JPY)
Mar 2021
-2,939
Mar 2022
-24,343
Mar 2023
-39,494
Mar 2024
-7,817
Mar 2025
-3,363
Cash flows from financing activities(million JPY)
Mar 2021
-16,003
Mar 2022
-16,471
Mar 2023
-43,541
Mar 2024
-25,248
Mar 2025
-25,947
Return on equity(%)
Mar 2021
4.7
Mar 2022
5.6
Mar 2023
7.1
Mar 2024
7.1
Mar 2025
6.6
Equity ratio(%)
Mar 2021
31.1
Mar 2022
31
Mar 2023
32.9
Mar 2024
33.4
Mar 2025
33.9
Earnings per share(JPY per share)
Mar 2021
113.96
Mar 2022
140.14
Mar 2023
184.82
Mar 2024
195.83
Mar 2025
193.2
Net assets per share(JPY per share)
Mar 2021
2,490.98
Mar 2022
2,525.72
Mar 2023
2,673.62
Mar 2024
2,858.57
Mar 2025
2,979.39
Dividend per share(JPY per share)
Mar 2021
42
Mar 2022
44
Mar 2023
46
Mar 2024
60
Mar 2025
62
Payout ratio(%)
Mar 2021
36.86
Mar 2022
31.4
Mar 2023
24.89
Mar 2024
30.64
Mar 2025
32.09
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.